Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high739.5 28/09/16
52 week low492.8 16/06/16
52 week change 32.5 (4.75%)
4 week volume7,351,923 05/09/16

Latest NewsMore

Broker Forecast - Numis issues a broker note on Clinigen Group

Numis today reaffirms its buy investment rating on Clinigen Group (LON:CLIN) and set its price target at 933p.

Clinigen's divi

Clinigen's adjusted gross profit rose by 90% to 102.1n in the year tot he end of June driven by acquisitions and organic grow...

Directorate Change

RNS Number: 0100L Clinigen Group plc 28 September 2016 28 September 2016 Shaun Chilton to take over as Chief Executive Officer Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services group, has been notified by Peter George that he intends to step down as Chief Executive Officer ('CEO') on 11 November 2016. He will con...

Final Results

RNS Number: 0089L Clinigen Group plc 28 September 2016 28 September 2016 TRANSFORMATIONAL YEAR DELIVERS 25% GROWTH IN ADJUSTED EPS* Clinigen Group plc (AIM: CLIN, 'Clinigen' or 'the Group'), the global pharmaceuticals and services group, has today published its full year results for the year ended 30 June 2016. FINANCIAL SUMMARY ...

Notification of Capital Markets Day

RNS Number: 9655K Clinigen Group plc 27 September 2016 27 September 2016 Notification of Capital Markets Day Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the global pharmaceutical and services company, will hold a Capital Markets Day on Friday 4 November 2016. The event will be held at Instinctif Partners' offices, 65 Gresham Street, London EC...

Clinigen and Cumberland launch Ethyol in US

Clinigen Group and Cumberland Pharmaceuticals have announced that Cumberland has launched Ethyol (amifostine) fo...

Clinigen and Cumberland launch Ethyol in the US

RNS Number: 8347K Clinigen Group plc 26 September 2016 26 September 2016 Clinigen Group and Cumberland Pharmaceuticals launch Ethyol in the U.S. Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, and Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX, 'Cumberland'), a specialty pharmaceutical comp...

Holding(s) in Company

RNS Number: 3509K Clinigen Group plc 20 September 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Clinigen Group Plc Ord GBP 0.01 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting ri...

Fundamental DataMore

P/E ratio60.252
EPS11.9
Dividend yield0.558 %

Equity Research (CLIN)

edison investment research
Clinigen Group Plc
01/03/2016
Edison Investment Research is terminating coverage on Clinigen Group (CLIN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be...
edison investment research
Clinigen Group Plc
25/01/2016
Clinigen’s H116 trading statement suggests its business is performing to plan, taking into account some revenue deferrals to H2. The integration of Idis and Link, which we expect to boost its...
edison investment research
Clinigen Group Plc
13/10/2015
Clinigen’s FY15 results demonstrated strong underlying fundamentals, with earnings and net debt better than our forecasts. The integration of Idis and the purchase of Link further its strategy as the...

Latest discussion posts More

  • Re: Well done Clinigen

    Just wished had topped up the days after Brexit! Like you said pharmaspecialist, debt down is always great to see, and the integration of the purchased businesses is being ...
    20-Jul-2016
    bushwhacker
  • Well done Clinigen

    Excellent results out today and I think justify the 11% share price increase at the time of writing. The results have also been achieved whilst lowering debt so they are real. ...
    20-Jul-2016
    pharmaspecialist
  • Results

    Looking forward to Wednesday's results.
    18-Jul-2016
    bushwhacker

Users' HoldingsMore

Users who hold Clinigen Group also hold..
GLAXOSMITHKLINE21%
TELFORD HOMES18%
RDS 'B'18%
NATIONAL GRID16%
LLOYDS GRP.16%

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN